Skip to content

The open randomized controlled multicenter clinical study of the treatment of connective tissue diseases related interstitial lung disease with cyclophosphamide and mycophenolate mofetil

The open randomized controlled multicenter clinical study of the treatment of connective tissue diseases related interstitial lung disease with cyclophosphamide and mycophenolate mofetil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONRC-12002259
Enrollment
Unknown
Registered
2012-06-08
Start date
2012-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

connective tissue diseases related interstitial lung disease

Interventions

CYC group:CYC
MMF group:MMF

Sponsors

Guangdong General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. To meet the various connective tissue disease diagnostic criteria; 2. Have cough, sputum production, chest tightness, chest pain and shortness of breath and other respiratory performance, and to exclude obstructive ventilatory defect; 3. Lung function: a restrictive ventilatory dysfunction, gas dispersion function was reduced; 4. The image changes of HRCT examination revealed ground-glass, grid -like, honeycomb-like fiber cords shadow and cystic degeneration; 5. Lung biopsy performance in line with the 2002 ATS / ERS developed seven pathological manifestations.

Exclusion criteria

Exclusion criteria: 1. ILD caused by the non- CTD 2. Pregnancy, lactation, beyond the control of congestive heart failure, severe diarrhea; 3. acute infection or malignancy; 4. severe pulmonary hypertension; 5. serum creatinine >=2.0 mg/dl; 6. Liver function >=2 times the upper limit of normal.

Design outcomes

Primary

MeasureTime frame
pulmonary function;lung CT;arterial blood gas analysis;BDI and TDI;SF-36;

Secondary

MeasureTime frame
ESR and CRP;NT-proBNP;

Countries

China

Contacts

Public ContactXiao Zhang
xiaozhang640@sohu.com+86 020 83883539

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026